Leukemia Research
Volume 27, Issue 7 , Pages 627-633 , July 2003

Coincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22–q34 in non-Hodgkin’s lymphomas

  • Bárbara Meléndez

      Affiliations

    • Dpto. Genética Humana, Programa Patologı́a Molecular, Centro Nacional Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34-91-224-69-49; fax: +34-91-224-69-23.
    • ,
  • Marta Cuadros

      Affiliations

    • Dpto. Genética Humana, Programa Patologı́a Molecular, Centro Nacional Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain
    • ,
  • Mercedes Robledo

      Affiliations

    • Dpto. Genética Humana, Programa Patologı́a Molecular, Centro Nacional Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain
    • ,
  • Carmen Rivas

      Affiliations

    • Dpto. Anatomı́a Patológica, Fundación Jiménez Dı́az, 28040 Madrid, Spain
    • ,
  • José Fernández-Piqueras

      Affiliations

    • Laboratorio de Genética Molecular Humana, Universidad Autónoma de Madrid, 28049 Madrid, Spain
    • ,
  • Beatriz Martı́nez-Delgado

      Affiliations

    • Dpto. Genética Humana, Programa Patologı́a Molecular, Centro Nacional Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain
    • ,
  • Javier Benı́tez

      Affiliations

    • Dpto. Genética Humana, Programa Patologı́a Molecular, Centro Nacional Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain

Received 30 May 2002 ,Accepted 1 November 2002.

References 

  1. Wiseman RW, Cochran C, Dietrich W, Lander ES, Söderkvist P. Allelotyping of butadiene-induced lung and mammary adenocercinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc. Natl. Acad. Sci. U.S.A. 1994;91:3759–3763
  2. Herzog CR, Chen B, Wang Y, Schut HAJ, You M. Loss of heterozygosity on chromosomes 1, 11, 12 and 14 in hybrid mouse lung adenocarcinomas. Mol. Carcinogenesis. 1996;16:83–90
  3. Santos J, Perez de Castro I, Herranz M, Pellicer A, Fernandez-Piqueras J. Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in γ-radiation-induced thymic lymphomas. Oncogene. 1996;12:669–676
  4. Santos J, Herranz M, Perez de Castro I, Pellicer A, Fernandez-Piqueras J. A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4. Oncogene. 1998;17:925–929
  5. Santos J, Herranz M, Fernández M, Vaquero C, Lopez P, Fernandez-Piqueras J. Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in gamma-radiation-induced thymic lymphomas. Oncogene. 2001;20:2186–2189
  6. Zhuang SM, Eklund LK, Cochran C, Rao GN, Wiseman RW, Söderkvist P. Allelotype analysis of 2′,3′-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice. Cancer Res. 1996;56:3338–3343
  7. Meléndez B, Santos J, Fernandez-Piqueras J. Loss of heterozygosity at the proximal-mid part of mouse chromosome 4 defines two novel tumor suppressor gene loci in T-cell lymphomas. Oncogene. 1999;18:4166–4169
  8. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta. 1998;1378:F115–F177
  9. Okumoto M, Park Y-G, Song C-W, Mori N. Frequent loss of heterozygosity on chromosomes 4, 12 and 19 in radiation-induced lymphomas in mice. Cancer Lett. 1999;135:223–228
  10. Park YG, Song CW, Mori N, Sugimoto K, Hong DP, Okumoto M. Analysis of highly frequent allelic loss region on distal chromosome 12 in murine radiation-induced lymphomas. Cancer Lett. 2000;148:95–103
  11. Stern MC, Benavides F, Klingelberger EA, Conti CJ. Allelotype analysis of chemically induced squamous cell carcinomas in F1 hybrids of two inbred mouse strains with different susceptibility to tumor progression. Carcinogenesis. 2000;21:1297–1301
  12. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943–1947
  13. Garcia MJ, Martinez-Delgado B, Granizo JJ, Benitez J, Rivas C. IgH, TCR-gamma, and TCR-beta gene rearrangement in 80 B- and T-cell non-Hodgkin’s lymphomas: study of the association between proliferation and the so-called “aberrant” patterns. Diagn. Mol. Pathol. 2000;10:69–77
  14. Fernandez-Piqueras J, Santos J, Perez de Castro I, Melendez B, Martinez B, Robledo M, et al.  Frequent allelic losses of 9p21 markers and low incidence of mutations at p16CDKN2 gene in non-Hodgkin lymphomas of B-cell lineage. Cancer Genet. Cytogenet. 1997;981:63–68
  15. Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, et al.  Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res. 1997;57:4710–4713
  16. Risinger JI, Hayes AK, Berchuck A, Barrett JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 1997;57:4736–4738
  17. Martinez-Delgado B, Fernandez-Piqueras J, Garcı́a MJ, Arranz E, Gallego J, Rivas C, et al.  Hypermethylation of a 5′ CpG island of p16 is a frequent event in non-Hodgkin’s lymphoma. Leukemia. 1997;11:425–428
  18. Chaganti SR, Gaidano G, Louie DC, Dalla-Favera R, Chaganti RS. Diffuse large cell lymphomas exhibit frequent deletions in 9p21–22 and 9q31–34 regions. Genes Chromosomes Cancer. 1995;12:32–36
  19. Simoneau AR, Spruck CH, Gonzalez-Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, et al.  Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for Gas1 and PTC mutations. Cancer Res. 1996;56:5039–5043
  20. Habuchi T, Luscombe M, Elder PA, Knowles MA. Structure and methylation-based silencing of a gene DBCCR1 within a candidate bladder cancer tumor suppressor region at 9q32–q33. Genomics. 1998;48:277–288
  21. McGarvey TW, Maruta Y, Tomaszewski JE, Linnenbach AJ, Malkowicz SB. PTCH gene mutations in invasive transitional cell carcinoma of the bladder. Oncogene. 1998;17:1167–1172
  22. Schiemann WP, Pfeifer WM, Levi E, Kadin ME, Lodish HF. A deletion in the gene for transforming growth factor β type I receptor abolishes growth regulation by transforming growth factor β in a cutaneous T-cell lymphoma. Blood. 1999;8:2854–2861
  23. Cook AL, Pollock PM, Welch J, Walsh MD, Bowman RV, Baumann KC, et al.  CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine Merkel cell carcinoma of the skin. Int. J. Cancer. 2001;93:361–367
  24. Pollock PM, Welch J, Hayward NK. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Res. 2001;61:1154–1161
  25. Bieche I, Khodja A, Lidereau R. Deletion mapping of chromosomal region 1p32-pter in primary breast cancer. Genes Chromosomes Cancer. 1999;24:255–263
  26. Imyanitov EN, Birrell GW, Filippovich I, Sorokina N, Arnold J, Mould MA, et al.  Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but gene encoding p73 is unlikely to be the target. Oncogene. 1999;18:4640–4642
  27. Caron H, Spieker N, Godfried M, Veenstra M, Van Sluis P, de Kreker J, et al.  Chromosome bands 1p35–36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer. 2001;30:168–174
  28. Herranz M, Urioste M, Santos J, Martinez-Delgado B, Rivas C, Benitez J, et al.  Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas. Leukemia. 2000;14:1325–1327
  29. Martinez-Delgado B, Melendez B, Cuadros M, Jose Garcia M, Nomdedeu J, Rivas C, et al.  Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin’s lymphomas. Int. J. Cancer. 2002;102:15–19
  30. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB, et al.  Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt’s lymphoma is associated with 5′ CpG island methylation. Cancer Res. 1999;59:3352–3356
  31. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, et al.  Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl. Cancer Inst. 2000;92:924–930
  32. Gronbaek K, Zeuthen J, Guldberg P, Ralfkiaer E, Hou-Jensen K. Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood. 1998;91:4388–4390
  33. Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M. PTEN gene alterations in lymphoid neoplasms. Blood. 1998;92:3410–3415
  34. Butler MP, Wang SI, Chaganti RSK, Parsons R, Dalla-Favera R. Analysis of PTEN mutations and deletions in B-cell non-Hodgkin’s lymphomas. Genes Chromosomes Cancer. 1999;24:322–327
  35. Siebert R, Gesk S, Harder S, Plotz S, Matthiesen P, Grote W, et al.  Deletions in the long arm of chromosome 10 in lymphomas with t14;18: a pathogenetic role of the tumor suppressor genes PTEN/MMAC1 and MXI1?. Blood. 1998;92:4487–4489
  36. Scarisbrick JJ, Woolford AJ, Russell-Jones R, Whittaker SJ. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood. 2000;95:2937–2942
  37. Robledo M, Martinez B, Arranz E, Trujillo MJ, Gonzalez Ageitos A, Rivas C, et al.  Genetic instability of microsatellites in hematological neoplasms. Leukemia. 1995;9:960–964
  38. Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet. 1994;6:273–281
  39. Cañamero M. Linfomas tı́micos murinos inducidos con radiación gamma: caracterización morfológica, IHQ, ultraestructural y genética. Madrid: Universidad Autónoma de Madrid, 2001.
  40. Cleary H, Boulton E, Plumb M. Allelic loss on chromosome 4 Lyr2/TLSR5 is associated with myeloid, B-lympho-myeloid, and lymphoid B and T mouse radiation-induced leukemias. Blood. 2001;98:1549–1554
  41. Meijne E, Huiskamp R, Haines J, Moody J, Finnon R, Wilding J, et al.  Analysis of loss of heterozygosity in lymphoma and leukemia arising in F1 hybrid mice locates a common region of chromosome 4 loss. Genes Chromosomes Cancer. 2001;31:373–381

PII: S0145-2126(02)00278-3

doi: 10.1016/S0145-2126(02)00278-3

Leukemia Research
Volume 27, Issue 7 , Pages 627-633 , July 2003

Article Tools

* Image Usage & Resolution